Screener
Lexicon Pharmaceuticals LXRX License — Net product and licensing revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Net product revenue | $680 | $1,322 | $1,770 | $2,584 |
| Licensing and milestone revenue | — | 27,544 | 20,000 | 27,544 |
| Royalties and other revenue | 12 | — | 24 | — |
| Total revenues | 692 | 28,866 | 21,794 | 30,128 |
| Operating expenses: | ||||
| Cost of sales | 39 | 33 | 147 | 63 |
| Research and development, including stock-based compensation of $1,384, $1,620, $2,753, and $3,194 respectively | 17,443 | 15,747 | 30,199 | 31,050 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's license — net product and licensing revenue?
- Lexicon Pharmaceuticals (LXRX) reported license — net product and licensing revenue of $0 in Q2 2026.
- How has Lexicon Pharmaceuticals's license — net product and licensing revenue changed year-over-year?
- Lexicon Pharmaceuticals's license — net product and licensing revenue decreased by 100.0% year-over-year, from $27.54M to $0.
- What does license — net product and licensing revenue mean?
- This metric represents the total revenue generated from the sale of pharmaceutical products and the licensing of intellectual property within a specific business segment. It reflects the company's ability to monetize its drug portfolio through both direct commercial sales and strategic partnership agreements. Growth in this figure indicates successful market adoption and effective commercialization strategies.
Ask your AI about Lexicon Pharmaceuticals's license — net product and licensing revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude